|
⚲
|
| Keyboard |
| David Scheinberg | |
|---|---|
| Firm | |
| Address | 7 Times Square Suite 2503 New York, NY 10036 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Sellas Life Sciences Group Inc | 021-509138 | Director | 18.4 M of 18.4 M |
||
| Sellas Life Sciences Group Inc | 021-374517 | Director | 9.2 M of 9.2 M |
||
| Sapience Therapeutics Inc | 021-370845 | Director | 8.0 M of 30.0 M |
||
| Progenics Pharmaceuticals Inc | 021-190883 | Director | 12.9 M | ||
| Contrafect Corp | 021-165957 | Director | 12.5 M of 25.0 M |
||
| Contrafect Corp | 021-146798 | Director | 4.3 M of 10.0 M |
||